BLU

Blue Chip Value Fund, Inc.
3.80
0.00 (0.0%)

BELLUS Health Inc. (BLU) Fundamentals

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The Company operates in one business segment namely, development of drug candidates for health solutions.
SHARE INFORMATION
Market Cap$ 1,500,512,082
Shares Outstanding207,253,050
Float207,253,050
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0.00
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions15
Institutional Holdings Date2012-05-01
Institutional Bought Previous 3 Months44,245,491
Institutional Holdings Percent33.4%
Institutional Sold Previous 3 Months23,793
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 7.88
52 Week Low$ 7.09
52 Week High Change$ 0.00
21 Day Moving Average$ 0.00
21 Day Extended Moving Average$ 0.00
50 Day Moving Average$ 0.00
50 Day Extended Moving Average$ 0.00
200 Day Moving Average$ 0.00
200 Day Extended Moving Average$ 0.00
10 Day Average Volume146,025
20 Day Average Volume73,012
30 Day Average Volume0.00
50 Day Average Volume0.00
Alpha-
Beta-
Standard Deviation-
R2-
7 Day Price Change$ -0.020001
7 Day Percent Change-0.28%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.00
Year to Date Percent Change0.0%

BELLUS Health Inc. (BLU) Key Ratios

PROFITABILITY
EBIT Margin-52,448.6%
EBITDA Margin-52,448.6%
Pre-Tax Profit Margin-5,449.1%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0.00
Revenue Per Share$ 0.0002
Revenue (3 Years)$ -76.48
Revenue (5 Years)$ -60.85
FINANCIAL STRENGTH
Price to Tangible Book-0.10
Total Debt To Equity0.00
Int Coverage-1,412.10
Current Ratio6.10
Leverage Ratio1.10
Quick Ratio6.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0.00
Price to Sales42,871.773
Price to Free Cash-1.40
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow-1.60
PE Low Last 5 Years0.00
Price to Tangible Book-0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-51.89
Return on Equity-58.81
Return on Capital-60.80

BELLUS Health Inc. (BLU) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEORoberto Bellini
Emplyoees10
Last AuditUQ
CIK0001259942
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address275 Armand-Frappier Boulevard
Laval, QC H7V 4A7
Websitehttp://www.bellushealth.com
Facsimile+1 450 680-4501
Telephone+1 450 680-4525
Emailir@bellushealth.com


Your Recent History
NYSE
BLU
Blue Chip ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.